SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-106359
Filing Date
2024-09-13
Accepted
2024-09-13 16:12:08
Documents
11
Period of Report
2024-09-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20240912.htm   iXBRL 8-K 38290
  Complete submission text file 0000950170-24-106359.txt   151625

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240912.xsd EX-101.SCH 25032
13 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240912_htm.xml XML 4673
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 241297845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)